Literature DB >> 22851333

Coronary microvascular function in patients with Cushing's syndrome.

Francesco Fallo1, Giulia Famoso, Dario Capizzi, Nicoletta Sonino, Francesca Dassie, Pietro Maffei, Chiara Martini, Agostino Paoletta, Sabino Iliceto, Francesco Tona.   

Abstract

The aim of the study was to evaluate patients with Cushing's syndrome the coronary flow reserve (CFR), an index of coronary microvascular function. Fifteen newly diagnosed patients with Cushing's syndrome (1 male/14 females; mean age 45 ± 11 years), were selected for having no clinical evidence of ischemic heart disease. Twelve patients had pituitary-dependent Cushing's disease and three had an adrenal adenoma. Fifteen subjects matched for age, sex, and major cardiovascular risk factors were used as controls. Coronary flow velocity in the left anterior descending coronary artery was investigated by transthoracic Doppler echocardiography at rest and during adenosine infusion. CFR was obtained as the ratio hyperemic/resting diastolic flow velocity. A reduced coronary reserve (hyperemic/resting ratio ≤ 2.5) was found in 5/15 Cushing patients and 4/15 controls. In all patients with abnormal CFR, epicardial coronary stenosis was excluded by multi-slice computed tomographic coronary angiography. CFR was inversely related to urinary cortisol in patients with endogenous hypercortisolism (Spearman's rho = -0.57, P = 0.03), while no correlation was found in controls. Coronary microvascular function, as assessed by CFR, is pathologically reduced in a considerable number of patients with Cushing's syndrome without clinical symptoms of ischemic heart disease and in the absence of epicardial coronary artery lesions, as well as in controls matched for cardiovascular risk factors. The presence of comorbidities can explain this early coronary abnormality in both patients and controls. Whether urinary cortisol may be a predictor of coronary microvascular function in the setting of patients with Cushing's syndrome, needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22851333     DOI: 10.1007/s12020-012-9764-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  42 in total

Review 1.  Cushing's syndrome.

Authors:  M Boscaro; L Barzon; F Fallo; N Sonino
Journal:  Lancet       Date:  2001-03-10       Impact factor: 79.321

Review 2.  Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature.

Authors:  R N Clayton; D Raskauskiene; R C Reulen; P W Jones
Journal:  J Clin Endocrinol Metab       Date:  2010-12-30       Impact factor: 5.958

3.  Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome.

Authors:  Kai Hang Yiu; Nina Ajmone Marsan; Victoria Delgado; Nienke R Biermasz; Eduard R Holman; Johannes W A Smit; Richard A Feelders; Jeroen J Bax; Alberto M Pereira
Journal:  Eur J Endocrinol       Date:  2011-10-17       Impact factor: 6.664

Review 4.  How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids.

Authors:  Sharon L H Ong; Judith A Whitworth
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

5.  Glucocorticoids downregulate cyclooxygenase-1 gene expression and prostacyclin synthesis in fetal pulmonary artery endothelium.

Authors:  S S Jun; Z Chen; M C Pace; P W Shaul
Journal:  Circ Res       Date:  1999-02-05       Impact factor: 17.367

6.  Inhibitory effect of glucocorticoid on coronary artery endothelial function.

Authors:  Kestrel M Rogers; Christi A Bonar; Jaymie L Estrella; Shumei Yang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11       Impact factor: 4.733

7.  Coronary flow reserve in hypertensive patients with hypercholesterolemia and without coronary heart disease.

Authors:  Maurizio Galderisi; Giovanni de Simone; Silvana Cicala; Michele Parisi; Arcangelo D'Errico; Pasquale Innelli; Marcello de Divitiis; Sergio Mondillo; Oreste de Divitiis
Journal:  Am J Hypertens       Date:  2007-02       Impact factor: 2.689

8.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

Authors:  G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

Review 9.  Inflammation and cortisol response in coronary artery disease.

Authors:  Johnny Nijm; Lena Jonasson
Journal:  Ann Med       Date:  2009       Impact factor: 4.709

10.  Mechanism of the effects of glucocorticoids and mineralocorticoids on vascular smooth muscle contractility.

Authors:  L Kornel; W A Nelson; B Manisundaram; R Chigurupati; T Hayashi
Journal:  Steroids       Date:  1993-12       Impact factor: 2.668

View more
  10 in total

1.  Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing's syndrome.

Authors:  Andrea Rebellato; Andrea Grillo; Francesca Dassie; Nicoletta Sonino; Pietro Maffei; Chiara Martini; Agostino Paoletta; Bruno Fabris; Renzo Carretta; Francesco Fallo
Journal:  Endocrine       Date:  2014-01-10       Impact factor: 3.633

Review 2.  Managing Cushing's disease: the state of the art.

Authors:  Annamaria Colao; Marco Boscaro; Diego Ferone; Felipe F Casanueva
Journal:  Endocrine       Date:  2014-01-11       Impact factor: 3.633

3.  Left ventricular geometry and 24-h blood pressure profile in Cushing's syndrome.

Authors:  Eleonora Avenatti; Andrea Rebellato; Andrea Iannaccone; Marialberta Battocchio; Francesca Dassie; Franco Veglio; Alberto Milan; Francesco Fallo
Journal:  Endocrine       Date:  2016-05-14       Impact factor: 3.633

4.  The degree of urinary hypercortisolism is not correlated with the severity of cushing's syndrome.

Authors:  Valentina Guarnotta; Marco C Amato; Rosario Pivonello; Giorgio Arnaldi; Alessandro Ciresi; Laura Trementino; Roberto Citarrella; Davide Iacuaniello; Grazia Michetti; Chiara Simeoli; Annamaria Colao; Carla Giordano
Journal:  Endocrine       Date:  2016-03-10       Impact factor: 3.633

Review 5.  Clinical and biochemical manifestations of Cushing's.

Authors:  Georgia Ntali; Ashley Grossman; Niki Karavitaki
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

6.  Soluble TNFα-receptor 1 as a predictor of coronary calcifications in patients after long-term cure of Cushing's syndrome.

Authors:  María-José Barahona; Eugenia Resmini; David Viladés; José-Manuel Fernández-Real; Wifredo Ricart; José-María Moreno-Navarrete; Guillem Pons-Lladó; Rubén Leta; Susan M Webb
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

7.  Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography.

Authors:  Nicola M Neary; O Julian Booker; Brent S Abel; Jatin R Matta; Nancy Muldoon; Ninet Sinaii; Roderic I Pettigrew; Lynnette K Nieman; Ahmed M Gharib
Journal:  J Clin Endocrinol Metab       Date:  2013-04-04       Impact factor: 5.958

Review 8.  Coronary Microvascular Function and Beyond: The Crosstalk between Hormones, Cytokines, and Neurotransmitters.

Authors:  Carlo Dal Lin; Francesco Tona; Elena Osto
Journal:  Int J Endocrinol       Date:  2015-06-01       Impact factor: 3.257

9.  Cushing syndrome cardiomyopathy: an unusual manifestation of small-cell lung cancer.

Authors:  Srinath-Reddi Pingle; Tanvi Shah; Wassim Mosleh; Agnes S Kim
Journal:  ESC Heart Fail       Date:  2020-06-23

10.  Cardiac structure and function in Cushing's syndrome: a cardiac magnetic resonance imaging study.

Authors:  Peter Kamenický; Alban Redheuil; Charles Roux; Sylvie Salenave; Nadjia Kachenoura; Zainab Raissouni; Laurent Macron; Laurence Guignat; Christel Jublanc; Arshid Azarine; Sylvie Brailly; Jacques Young; Elie Mousseaux; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2014-08-05       Impact factor: 5.958

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.